NCT04431401View on ClinicalTrials.gov

rTMS Treatment of Primary Progressive Aphasia

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

August 31, 2022

Conditions
Primary Progressive AphasiaRepetitive Transcranical Magnetic Stimulation
Interventions
DEVICE

Magstim rTMS

The device is made in London,UK

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT04431401 - rTMS Treatment of Primary Progressive Aphasia | Biotech Hunter | Biotech Hunter